| Authors | فرزانه فرزاد,پریسا طاهرپورفیروزکوهی,سیدمحمدرضا گدازگربروجردی |
| Journal | Materials Chemistry and Physics |
| Page number | 1230-1237 |
| Serial number | ۱۳۳۲۳۶ |
| Volume number | ۳۷۱ |
| IF | 2.084 |
| Paper Type | Full Paper |
| Published At | ۲۰۲۶ |
| Journal Grade | ISI |
| Journal Type | Typographic |
| Journal Country | Iran, Islamic Republic Of |
| Journal Index | JCR،Scopus |
| Keywords | Molecular dynamics simulations, β, Cyclodextrin, Metal, Organic 25 Frameworks, Drug Adsorption, Anticancer Drugs, and Drug, Nanocarrier Interactions |
|---|
Abstract
Developing nanocarrier-based drug delivery systems with enhanced selectivity and
7 efficiency is crucial for optimizing cancer treatment while minimizing systemic toxicity.
8 In this study, we employed molecular dynamics (MD) simulations to investigate the
9 adsorption behavior and interaction mechanisms of four anticancer drugs, Fludarabine
10 (FLU), Carmustine (BCNU), Methotrexate (MTX), and Mitoxantrone (MIT), onto β-
11 cyclodextrin-based metal-organic frameworks (β-CD-MOFs). The results indicate that
12 electrostatic interactions, primarily hydrogen bonding and van der Waals forces, play a
13 dominant role in drug adsorption, with FLU exhibiting the highest binding affinity (-69.25
14 kJ/mol) due to its compact molecular structure and purine ring system. In contrast, BCNU
15 displayed the weakest interaction, likely due to its lower molecular density and higher
16 solubility. Radial distribution function (RDF) analysis revealed strong host-guest
17 interactions within the β-CD-MOF framework between 1 and 2.5 nm, while mean square
18 displacement (MSD) data suggested that FLU experiences reduced mobility throughout the
19 75,000 ps simulation, indicative of enhanced stability on the nanocarrier surface.
20 Overall, the simulations provide molecular-level insight into the relative interaction and
21 mobility of the investigated drugs on the β-CD-MOF surface. These computational
22 findings provide a basis for subsequent experimental investigation of drug loading, release
23 behavior, and biocompatibility.
Paper URL